Company Overview of Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB, together with its subsidiaries, develops, manufactures, and markets generic pharmaceuticals in Sweden and internationally. It provides a portfolio of generic pharmaceuticals in various therapeutic areas, such as cardiovascular, central nervous system, gastrointestinal, diabetes, oncology, dermatology, respiratory, inflammatory, genito-urinary, antifungal, antiviral, endocrinology, analgesic, and antibiotics. The company sells its products through a network of independent wholesalers and pharmacies. Bluefish Pharmaceuticals AB was founded in 2005 and is headquartered in Stockholm, Sweden.
Stockholm, 113 30
Founded in 2005
46 8 51 91 16 00
46 8 51 91 16 90
Key Executives for Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Key Developments
Similar Private Companies By Industry
|Aditech Pharma AB||Europe|
|Apotek Produktion & Laboratorier AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Bluefish Pharmaceuticals AB, please visit www.bluefishpharma.se. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.